✦ LIBER ✦

Alterations in baseline activity and quinpirole sensitivity in putative dopamine neurons in the substantia nigra and ventral tegmental area after withdrawal from cocaine pretreatment

✍ Scribed by Wei-Ying Gao; Tong H. Lee; George R. King; Everett H. Ellinwood

Book ID: 114282186
Publisher: Nature Publishing Group
Year: 1998
Tongue: English
Weight: 997 KB
Volume: 18
Category: Article
ISSN: 1470-634X
DOI: 10.1016/s0893-133x(97)00132-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel in vivo electrophysiological assay

Novel in vivo electrophysiological assay for the effects of cocaine and putative “cocaine antagonists” on dopamine transporter activity of substantia nigra and ventral tegmental area dopamine neurons

✍ Melissa A. Hinerth; Holly A. Collins; Marylynn Baniecki; Robert N. Hanson; Barba 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 2 views

Neurotensin attenuates the quinpirole-in

Neurotensin attenuates the quinpirole-induced inhibition of the firing rate of dopamine neurons in the rat substantia nigra pars compacta and the ventral tegmental area

✍ T.R Werkman; C.G Kruse; H Nievelstein; S.K Long; W.J Wadman 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 235 KB

Differential effects of SCH 23390 on the

Differential effects of SCH 23390 on the apomorphine subsensitivity in the substantia nigra and ventral tegmental area 1 day following withdrawal from continuous or intermittent cocaine pretreatment

✍ Tong H. Lee; Wei-Ying Gao; Everett H. Ellinwood 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 567 KB

Comparison of the effects of the cholecy

Comparison of the effects of the cholecystokinin-B receptor antagonist, PD 134308, and the cholecystokinin-A receptor antagonist, L-364,718, on dopamine neuronal activity in the substantia nigra and ventral tegmental area

✍ Leonard T. Meltzer; Curt L. Christoffersen; Kevin A. Serpa; Ahmad Razmpour 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 686 KB

Extracellular single-unit recording techniques were used to study the effects of the cholecystokinin-A (CCK-A) antagonist, L-364,718, and the CCK-B antagonist, PD 134308, on DA neuronal activity in chloral hydrate anesthetized rats. Neither L-364,718 (0.1-1.6 m g k g i.v.) nor PD 134308 (0.1-6.4 mgk